FORWARD PHARMA A/S
SPONSORD ADS NEW · CUSIP 34986J204
1
institutional holders
-1 vs Q4 2022
150.2k
shares reported held*
$323.0kreported value*
0 new
0 added
0 reduced
1 sold out
net sold ≈ $132.2k (-61.5k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.15.
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 8 |
| Q4 2022 | 2 |
| Q1 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 6 |
| Q1 2023 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| ACADIAN ASSET MANAGEMENT LLC | Sold out | -61.5k |
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| MASON CAPITAL MANAGEMENT LLC 0.14% of their portfolio | 150.2k $323.0k | Unchanged |